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Abstract: Zirconia (ZrO2) and barium sulfate (BaSO4) particles were introduced into a methyl 
methacrylate monomer (MMA) solution with polymethyl methacrylate (PMMA) beads during 
polymerization to develop the following novel bone cements: bone cements with unfunctionalized 
ZrO2 micron particles, bone cements with unfunctionalized ZrO2 nanoparticles, bone cements 
with ZrO2 nanoparticles functionalized with 3-(trimethoxysilyl)propyl methacrylate (TMS), bone 
cements with unfunctionalized BaSO4 micron particles, bone cements with unfunctionalized 
BaSO4 nanoparticles, and bone cements with BaSO4 nanoparticles functionalized with TMS. 
Results demonstrated that in vitro osteoblast (bone-forming cell) densities were greater on bone 
cements containing BaSO4 ceramic particles after four hours compared to control unmodified 
bone cements. Osteoblast densities were also greater on bone cements containing all of the 
ceramic particles after 24 hours compared to unmodified bone cements, particularly those bone 
cements containing nanofunctionalized ceramic particles. Bone cements containing ceramic 
particles demonstrated significantly altered mechanical properties; specifically, under tensile 
loading, plain bone cements and bone cements containing unfunctionalized ceramic particles 
exhibited brittle failure modes whereas bone cements containing nanofunctionalized ceramic 
particles exhibited plastic failure modes. Finally, all bone cements containing ceramic particles 
possessed greater radio-opacity than unmodified bone cements. In summary, the results of 
this study demonstrated a positive impact on the properties of traditional bone cements for 
orthopedic applications with the addition of unfunctionalized and TMS functionalized ceramic 
nanoparticles.
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Introduction
Polymethyl methacrylate (PMMA) bone cement is frequently used in the fixation 
of orthopedic implants. While it is widely accepted that PMMA has satisfactory 
biocompatibility properties that warrant its use in orthopedics, PMMA is notorious 
for eliciting an autoimmune response that may manifest in fibrous encapsulation or 
inflammation, both of which contribute to possible subsequent implant loosening and 
failure.1,2 This implant failure is often exacerbated by wear debris generated from 
brittle bone cement use, a direct product of dynamic mechanical forces acting on 
PMMA in vivo. PMMA is known to fail in vivo, being cited as the weakest portion of 
the joint–implant system.3,4 Perhaps contributing to its suboptimal cytocompatibility 
properties, PMMA is known to be highly exothermic during polymerization, often 
leading to tissue necrosis during initial placement at the joint–implant interface.5 
In particular, Boner and colleagues have reported a high risk of tissue necrosis International Journal of Nanomedicine 2010:5 
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anytime the thickness of PMMA exceeds 5.0 mm around 
the implant.6
While there have been many attempts to improve properties 
of bone cements, few have employed nanotechnology 
(or the use of materials with one dimension less than 
100 nm). Along this line, ceramic particles, such as zirconia 
(ZrO2) and barium sulfate (BaSO4), are often introduced 
into bone cements to increase radio-opacity so that they 
may be visualized through X-ray imaging.7 The introduc-
tion of ceramics into bone cements has been shown by 
Sabokbar and colleagues to further negatively impact 
PMMA biocompatibility properties, often manifesting in 
the loosening of implants.3 Due to many studies which 
have demonstrated greater bone formation on implants 
with nanometer surface features, it is clear that changing 
the properties (such as particle size and even chemistry) of 
such ceramics added to bone cements may improve PMMA 
efficacy. Previous studies have shown that material (such 
as metals, ceramics, polymers, and composites thereof) 
modifications at the nanoscale, particularly texture and 
topographical modifications, increase surface wettability 
and in turn increase cytocompatibility properties.8
Another approach that may be taken in conjunction 
with nanoscale modification of ceramic particles added 
to bone cements is chemical functionalization of ceramic 
nanoparticles to allow for better integration with PMMA. 
Chemical functionalization of nanoparticles may also aid 
in cytocompatibility properties. For example, in previous 
studies, polar, nucleophilic groups have been shown to 
increase surface energy and wettability of implant surfaces 
allowing for the adsorption of select proteins, such as 
fibronectin and vitronectin, to promote osteoblast (bone-
forming cell) adhesion and proliferation.9
In this study, for the first time, bone cements were 
modified by adding unfunctionalized and functionalized ZrO2 
and BaSO4 particles. Specifically, some ceramic nanopar-
ticles were left unfunctionalized while some were functional-
ized with a silane-coupling agent 3-(trimethoxysilyl)propyl 
methacrylate (TMS). Bone cements were further seeded with 
osteoblasts and incubated for four and 24 hours. Scanning 
electron microscopy (SEM) imaging was used to examine 
ceramic particle dispersion in the bone cements to determine 
the relationship between particle dispersion and observed cell 
densities. Tensile and compressive tests were also carried out 
to characterize differences in stress–strain properties. SEM 
imaging was used to further characterize the mechanical 
failure modes of the bone cements in response to tensile 
loading. Exothermic testing was conducted on bone cements 
during polymerization in order to determine the impact 
of ceramic particles on PMMA heat generation. Finally, 
X-ray images of the bone cements were taken to determine 
how the novel ceramic particles influenced radio-opacity. 
Results provided much promise for the use of functional-
ized nanoceramic particles added to PMMA for orthopedic 
applications.
Materials and methods
Materials
Bone cements used in the cytocompatibility testing con-
sisted of a 5:1 ratio of liquid methyl methacrylate mono-
mer to polymethyl methacrylate (PMMA) beads (MMA, 
80-62-6; Polysciences, Inc., Warrington, PA, USA). Ten 
grams of liquid MMA were combined with 2 g of PMMA. 
Aside from the control unmodified bone cement samples, 
all samples contained an additional 1 g of one of the 
following ceramics: ZrO2 micron particles (1314-23-4; 
Sigma-Aldrich, St. Louis, MO, USA), unfunctionalized 
ZrO2 nanoparticles (NN-Labs, Fayetteville, AR, USA), 
ZrO2 nanoparticles functionalized with TMS (NN-Labs), 
BaSO4 micron particles (1142ZJ, NanoAmor, Houston, 
TX, USA), unfunctionalized BaSO4 nanoparticles (1141ZJ, 
NanoAmor), or BaSO4 nanoparticles functionalized with 
TMS (NN-Labs). Bone cements were made by adding 
PMMA beads into liquid MMA. The reaction was catalyzed 
with 1,1’-Azobis(cyclo-hexanecarbonitrile) (0.05% by 
mass of liquid MMA). After the addition of the catalyst, 
the PMMA-MMA mixtures were stirred vigorously in a 
70 °C hot water bath. For bone cements containing ceramic 
particles, the ceramic particles were stirred into the mixture 
for a total of five minutes until reaching a viscous consistency. 
Then, they were cast into polystyrene petri dishes, in which 
they were allowed to cool for a period of 48 hours. After 
setting, the bone cements were sectioned into approximately 
1 cm2 substrates for cytocompatibility testing.
cytocompatibility testing
The samples were soaked in 70% ethyl alcohol for 
sterilization purposes for approximately 10 minutes and 
subsequently seeded at a density of 3500 cells/cm2 with 
human osteoblasts (population numbers 6 to 12, American 
Type Culture Collection CEL-11372) in osteoblast cell 
culture medium (Dulbecco’s modified Eagle medium 
[DMEM]) supplemented with 10% fetal bovine serum 
(FBS) and 1% P/S. Prior to the experiment, osteoblasts were 
cultured in osteoblast cell culture medium under standard 
culture conditions (5% CO2/95% air at 37 °C). Cell-seeded International Journal of Nanomedicine 2010:5 
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samples were incubated at 37 °C for either four or 24 hours 
under standard cell culture conditions.
After incubation, samples were rinsed with phosphate-
buffered saline (PBS) to remove nonadherent cells, and were 
subsequently fixed in 10% formaldehyde for 10 minutes. 
Then, samples were stained with 1% DAPI fluorescent dye 
(Sigma Aldrich) for 10 minutes. Cells were visualized using 
a fluorescence microscope (Leica DM 5500B; Leica, Austin, 
TX, USA) and cell densities were counted on five randomly 
selected sites on each sample. Experiments were conducted 
in duplicate and repeated at least three times.
Tensile and compressive  
mechanical testing
Bone cements used for mechanical testing were prepared 
using a protocol similar to that which was just described. 
The protocol only differed in the ratio of MMA to PMMA 
used in each sample: instead of a 5:1 ratio, a 1:1 ratio 
was used to fabricate bone cements that would solidify 
more quickly and allow for better dispersion of ceramic 
particles. In the preparation of each sample, 12 g of 
MMA were combined with 12 g of PMMA, while 2 g of 
one of the six ceramic particles (ZrO2 micron particles, 
unfunctionalized ZrO2 nanoparticles, ZrO2 nanoparticles 
functionalized with TMS, BaSO4 micron particles, unfunc-
tionalized BaSO4 nanoparticles, and BaSO4 nanoparticles 
functionalized with TMS) were added to the modified bone 
cements. The PMMA beads and ceramic particles were 
first introduced into a 50 mL beaker to a 70 °C water bath. 
Subsequently, the liquid phase of MMA with the dissolved 
1,1’-Azobis(cyclo-hexanecarbonitrile) catalyst was poured 
onto the solid phase and the resulting mixture was stirred 
vigorously and poured into a 250 mm × 25 mm × 2.5 mm 
Teflon mold. Bone cements were allowed to harden at room 
temperature for a period of 3–7 days, after which they were 
excised from the molds. A fine-tooth saw and vice were used 
to partition the larger samples into smaller rectangular samples 
for tensile and compressive mechanical testing. For tensile 
testing, specimens of dimensions 24.3 mm × 59.5 mm × 
1.8 mm were excised. For compressive testing, specimens of 
dimensions 24.3 mm × 10.3 mm × 1.8 mm were excised.
Specimens were tested for their tensile and compres-
sive properties using 500 N and 100 kN load cells (Instron 
5800 Electro-Mechanical Testing System; Instron Pty Ltd., 
Melbourne, Australia). Tensile specimens were clamped and 
extended at a rate of  2 mm/minute until failure. Compressive 
specimens were allowed to rest on a flat platform and 
were compressed 1 mm at a rate of 0.2 mm/minute. Due to 
geometrical constraints, compressive specimens were not 
compressed until failure. Cross-sectional force (1.8 mm × 
24.3 mm for tensile specimens and 10.3 mm × 1.8 mm for 
compressive specimens) was measured consistently through-
out extension and compression and stress-strain curves were 
developed for each of the samples. Three trials were averaged 
for all bone cements.
scanning electron microscopy
Using a LEO 1530VP SEM, the bone cements used in 
the cytocompatibility tests were characterized for ceramic 
particle dispersion and topography prior to testing. 
Additionally, bone cements used in the tensile tests were 
characterized for their mode of fracture. Samples were 
prepared for SEM by sputter-coating with gold and palladium 
for one minute.
Temperature measurements of bone 
cements during polymerization
To evaluate differences in exothermic properties, 0.75 g of 
MMA with the catalyst was poured into a glass test tube 
containing 0.75 g of PMMA beads as well as 0.25 g of the 
ceramic particles aside from the plain sample, in which 
no ceramic particles were added. The contents of the glass 
test tube were stirred vigorously in a 70 °C hot water bath 
until a temperature threshold of 60 °C was reached. At this 
time, the test tube was removed from the water bath and the 
temperature of the polymerizing bone cements was measured 
periodically over ten minutes using a Fluke 50 Series II 
contact thermometer (Fluke Electronics, Everett, WA, USA).
X-ray analysis of radio-opacity
Samples used in tensile and compressive testing were 
visualized for radio-opacity using a Bennett X-ray 
Technologies Model S-82RM (Bennett X-Ray Technologies, 
Copiague, NY, USA) machine. The resulting X-ray image 
was scanned using a HPColor Laserjet CM1015 scanner 
(Hewlett-Packard, Houston, TX, USA) for analysis of mean 
grey values (a measure of optical density) using ImageJ 
1.41 software (National Institutes of Health, Bethseda, 
MD, USA).
statistical analyses
Numerical data was analyzed using Microsoft Excel 
(Microsoft Corp., Redmond, WA, USA). One-tailed, 
heteroscedastic t-tests were used to analyze significant 
differences between bone cements in cytocompatibility 
testing.International Journal of Nanomedicine 2010:5 
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Results
scanning electron microscopy
Differences in ceramic particulate dispersion patterns could 
be clearly seen in the various bone cements formulated here 
(Figure 1). It appeared that micron particles were not as 
readily visible on the surface as they were immersed below 
the surface due to sedimentation. In contrast, functionalized 
nanoparticles could be easily seen on the surfaces of the 
bone cements. Bone cements containing functionalized ZrO2 
nanoparticles tended to aggregate more than their unfunc-
tionalized counterparts.
cytocompatibility testing
After four hours, osteoblast cell density assays demonstrated 
greater osteoblast adhesion on bone cements containing 
BaSO4 particles (P  0.05 for micron, P  0.05 for 
nanounfunctionalized, and P  0.005 for nanofunctional-
ized with TMS) compared to unmodified bone cements 
(Figure 2). The average cell densities (cells/cm2) for each type 
of bone cement, plus or minus one standard error, were as 
follows: unmodified bone cements (Plain): 298 ± 31.4, bone 
cements with BaSO4 micron particles (BM): 372.6 ± 36.9, 
bone cements with unfunctionalized BaSO4 nanoparticles 
(BN): 394 ± 49.2, bone cements with BaSO4 nanopar-
ticles functionalized with TMS (BNFT): 429 ± 43.5, bone 
cements with ZrO2 micron particles (ZM): 254 ± 44.6, 
bone cements with unfunctionalized ZrO2 nano particles 
(ZN): 288 ± 39.4, and bone cements with ZrO2 nanoparticles 
functionalized with TMS (ZNFT): 282 ± 32.2.
After 24 hours, results demonstrated greater osteoblast 
density on all bone cements containing ceramic particles 
(P  0.1 for BaSO4 micron particles, P  0.005 for 
unfunctionalized BaSO4 nanoparticles and ZrO2 nanopar-
ticles functionalized with TMS, and P  0.001 for BaSO4 
nanoparticles functionalized with TMS, ZrO2 micron 
particles, and unfunctionalized ZrO2 nanoparticles) com-
pared to unmodified bone cements (Figure 3). Additionally, 
compared to bone cements containing BaSO4 micron 
particles, osteoblast density was found to be greater on bone 
cements containing functionalized BaSO4 nanoparticles 
(P  0.1). Finally, compared to bone cements containing 
ZrO2 micron particles, osteoblast density was greater on bone 
cements containing ZrO2 nanoparticles, both unfunctional-
ized (P  0.05) and functionalized with TMS (P  0.1). 
The average cell densities (cells/cm2) for each type of bone 
cement, plus or minus one standard error, were as follows: 
unmodified bone cements (Plain): 869 ± 138.4, bone cements 
with BaSO4 micron particles (BM): 1098 ± 138.1, bone 
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Figure  seM images of bone cements used in cytocompatibility testing [Left: 
15K X (scale bar = 1 µm), Right: 50K X (scale bar = 100 nm)]: Plain (A, B), ZM (containing 
micron particulate ZrO2) (C, D), ZN (containing unfunctionalized ZrO2 nano-particles) 
(E, F), ZNFT (containing functionalized ZrO2 nano-particles) (G, H), BM (containing 
micron particulate BasO4) (I, J), BN (containing unfunctionalized BasO4 nano-particles) 
(K, L), and BNFT (containing functionalized BasO4 nano-particles) (M, N).
cements with unfunctionalized BaSO4 nanoparticles (BN): 
1335 ± 152.2, bone cements with BaSO4 nanoparticles func-
tionalized with TMS (BNFT): 1545 ± 167, bone cements with 
micron ZrO2 particles (ZM): 1440 ± 144.3, bone cements with 
unfunctionalized ZrO2 nanoparticles (ZN): 2104 ± 257.2, and 
bone cements with ZrO2 nanoparticles functionalized with 
TMS (ZNFT): 2039 ± 353.International Journal of Nanomedicine 2010:5 
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Fluorescence microscopy images of osteoblasts after the 
four- and 24-hour incubation periods, respectively, further 
demonstrated such trends (Figures 4 and 5). Lastly, the addi-
tion of ceramic particles and their subsequent nanoscaling and 
chemical functionalization with the silane-coupling agent TMS, 
was shown to have a positive impact on osteoblast densities.
Tensile and compressive mechanical testing
Most importantly, the results of this study showed a clear 
difference between the failure modes for the various 
bone cements fabricated in this study (Figures 6 and 7). 
Plain bone cements as well as bone cements containing 
unfunctionalized ceramic micron and nanoparticles had 
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Figure  Osteoblast cell density, after 4 hours, as a function of bone cement type. Data = mean +/- seM; N = 3. Plain = Unmodified bone cements; BM = Bone cements with 
micron particulate BasO4, BN = Bone cements with unfunctionalized BasO4 nanoparticles, BNFT = Bone cements with functionalized BasO4 nanoparticles;  ZM = Bone cements 
with micron particulate ZrO2,  ZN = Bone cements with unfunctionalized ZrO2 nanoparticles;  ZNFT = Bone cements with functionalized ZrO2 nanoparticles.
*compared to plain bone cement;  adhesion on bone cements containing the following ceramic particles was found to be greater:  micron particulate BasO4 (p  0.05), 
unfunctionalized BasO4 nano-particles (p  0.05), and BasO4 nano-particles functionalized with TMs (p  0.005).
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Figure  Osteoblast cell-density, after 24 hours, as a function of bone cement type. Data = mean +/- seM; N = 3. Plain = Unmodified bone cements, BM = Bone cements 
with micron particulate BasO4, BN = Bone cements with unfunctionalized BasO4 nanoparticles, BNFT = Bone cements with functionalized BasO4 nanoparticles, ZM = Bone 
cements with micron particulate ZrO2, ZN = Bone cements with unfunctionalized ZrO2 nanoparticles, ZNFT = Bone cements with functionalized ZrO2 nanoparticles. 
*compared to plain bone cement, adhesion on bone cements containing all ceramic particles was found to be greater: micron particulate BasO4 (p  0.1), unfunctionalized 
BasO4 nano-particles (p  0.005), ZrO2 nano-particles functionalized with TMs (p  0.005), BasO4 nano-particles functionalized with TMs (p  0.001), micron ZrO2 particles 
(p  0.001), and unfunctionalized ZrO2 nano-particles (p  0.001). Ψcompared to bone cements containing micron BasO4 particles, adhesion was found to be greater on 
bone cements containing BasO4 nano-particles functionalized with TMs (p  0.05). €WRT bone cements containing micron ZrO2 particles, adhesion was found to be greater 
on bone cements containing unfunctionalized ZrO2 nano-particles (p  0.05) and ZrO2 nano-particles functionalized with TMs (p  0.1).International Journal of Nanomedicine 2010:5 
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failure modes characteristic of brittle fracture, while bone 
cements containing functionalized ceramic nanoparticles had 
failure modes that were less brittle and had a clear plastic 
deformation region.
From the stress–strain data, the Young’s modulus and 
the maximum stress under tensile loading conditions were 
calculated for all bone cements. This data, along with 
the Young’s moduli of cortical and trabecular bone, are 
presented in Table 1 and Figures 6 and 7.10 The maximum 
stress for each type of bone cement was: unmodified bone 
cements (Plain): 1.30E + 07 N/m2, bone cements with 
BaSO4 micron particles (BM): 1.25E + 07 N/m2, bone 
cements with unfunctionalized BaSO4 nanoparticles (BN): 
1.00E+07 N/m2, bone cements with BaSO4 nanoparticles 
E)
D) C) B) A)
G) F)
Figure  Fluorescence microscopy images (magnification = 10X) of osteoblasts after 24 hours of proliferation on different bone cements: A) Plain, B) ZM (containing 
micron particulate ZrO2), C) ZN (containing unfunctionalized ZrO2 nano-particles), D) ZNFT (containing ZrO2 nano-particles functionalized with TMs, E) BM 
(containing micron particulate BasO4), F) BN (containing unfunctionalized BasO4 nano-additives), and G) BNFT (containing BasO4 nano-additives functionalized with TMs).
A)
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G) F)
Figure  Fluorescence microscopy images (magnification = 10X) of osteoblasts after 4 hours of adhesion on different bone cements: A) Plain, B) ZM (containing micron 
particulate ZrO2), C) ZN (containing unfunctionalized ZrO2 nano-particles), D) ZNFT (containing ZrO2 nano-particles functionalized with TMs, E) BM (containing 
micron particulate BasO4), F) BN (containing unfunctionalized BasO4 nano-additives), and G) BNFT (containing BasO4 nano-additives functionalized with TMs).International Journal of Nanomedicine 2010:5 
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Nanofunctionalized ZrO2 and BasO4 as bone cement additives
functionalized with TMS (BNFT): 1.16E + 07 N/m2, 
bone cements with ZrO2 micron particles (ZM): 1.28E 
+ 07 N/m2, bone cements with unfunctionalized ZrO2 
nanoparticles (ZN): 9.32E + 06 N/m2, and bone cements 
with ZrO2 nanoparticles functionalized with TMS (ZNFT): 
9.88E + 06 N/m2. The Young’s modulus for each type of bone 
cement was found as follows: unmodified bone cements 
(Plain): 6.74E + 08 N/m2, bone cements with BaSO4 
micron particles (BM): 2.98E + 08 N/m2, bone cements 
with unfunctionalized BaSO4 nanoparticles (BN): 2.38E + 
08 N/m2, bone cements with BaSO4 nanoparticles function-
alized with TMS (BNFT): 2.55E + 08 N/m2, bone cements 
with ZrO2 micron particles (ZM): 2.77E + 08 N/m2, bone 
cements with unfunctionalized ZrO2 nanoparticles (ZN): 
3.16E + 08 N/m2, and bone cements with ZrO2 nanoparticles 
functionalized with TMS (ZNFT): 1.89E + 08 N/m2.
After tensile testing, SEM was used to characterize the 
fractured planes in the bone cements (Figure 8). Results 
strongly support the suggested failure modes as observed 
during tensile testing. It was apparent that for bone cements 
undergoing brittle fracture, plain bone cements as well as 
bone cements with unfunctionalized ceramic micron and 
nanoparticles, there was clean separation of the polymer 
matrix from itself, as well as from the dispersed ceramic 
particles; this was observed particularly well in bone cements 
containing micron ZrO2 particles. In bone cements with 
ceramic nanoparticles, while the polymer separation from 
the ceramic particles wasn’t as readily apparent, jagged 
and complete fracture lines indicative of a brittle failure 
mode were easily observed. For bone cements containing 
functionalized ceramic nanoparticles, plastic failure was 
observed by the incomplete separation within the polymer 
matrix, as well as a better integration of ceramic particles 
into the polymer matrix.
Because compressive testing was not carried out to 
failure, the most meaningful data that could be derived from 
the stress–strain curves was the stress required to achieve a 
maximum strain of 56% (occurring at 1 mm of compression) 
(Table 2). The maximum compressive stress for each type 
of bone cement was: unmodified bone cements (Plain): 
3.63E + 07 N/m2, bone cements with BaSO4 micron particles 
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Figure  Representative tensile stress-strain curves for various bone cements. One 
representative of three trials is shown for each bone cement. Bone cements tested 
included: Plain, ZM (containing micron particulate ZrO2), ZN (containing unfunction-
alized ZrO2 nano-particles), ZNFT (containing functionalized ZrO2 nano-particles), 
BM (containing micron particulate BasO4), BN (containing unfunctionalized BasO4 
nano-particles), and BNFT (containing functionalized BasO4 nano-particles). A) All 
bone cements, B) Bone cements containing ZrO2 particles, and C) Bone cements 
containing BasO4 particles.
Table  Maximum stresses and Young’s moduli of various bone 
cements under tension: Plain, ZM (containing micron particulate 
ZrO2), ZN (containing unfunctionalized ZrO2 nano-particles), 
ZNFT (containing functionalized ZrO2 nano-particles), BM 
(containing micron particulate BasO4), BN (containing unfunctional-
ized BasO4 nano-particles), and BNFT (containing functionalized 
BasO4 nano-particles). Young’s moduli values for bone obtained 
from study by Mente et al
Substrate  Maximum stress  
(N/m)
Young’s modulus   
(N/m)
Plain 1.30e + 07 6.74e + 08
ZNFT 9.88e + 06 1.89e + 08
ZN 9.32e + 06 3.16e + 08
ZM 1.28e + 07 2.77e + 08
BNFT 1.16e + 07 2.55e + 08
BN 1.00e + 07 2.38e + 08
BM 1.25e + 07 2.98e + 08
cortical bone – dry 1.82e + 10
cortical bone – wet 1.24e + 10
Trabecular bone – dry   7.80e + 09International Journal of Nanomedicine 2010:5 
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to the present study during polymerization (data not 
shown).
X-ray analysis of radio-opacity
Results demonstrated that the radio-opacity of all bone 
cements with ceramic particles was greater than that of plain 
bone cements (Table 3).
(BM): 9.71E + 06 N/m2, bone cements with unfunctional-
ized BaSO4 nanoparticles (BN): 2.36E + 07 N/m2, bone 
cements with BaSO4 nanoparticles functionalized with 
TMS (BNFT): 1.90E + 07 N/m2, bone cements with ZrO2 
micron particles (ZM): 7.50E + 07 N/m2, bone cements with 
unfunctionalized ZrO2 nanoparticles (ZN): 1.04E + 07 N/m2, 
and bone cements with ZrO2 nanoparticles functionalized 
with TMS (ZNFT): 2.36E + 07 N/m2.
Temperature measurements of bone 
cements during polymerization
Results of the exothermic testing showed no significant 
differences in temperature for any of the samples of interest 
A)
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F)
H)
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L)
N)
Figure  seM images of bone cements fractured in tension [Left: 5K X (scale 
bar = 3 µm), Right: 15K X (scale bar = 1 µm)]: Plain (A, B), ZM (containing micron 
particulate ZrO2) (C, D), ZN (containing unfunctionalized ZrO2 nano-particles) (E, F), 
ZNFT (containing functionalized ZrO2 nano-particles) (G, H), BM (containing micron 
particulate BasO4) (I, J), BN (containing unfunctionalized BasO4 nano-particles) (K, L), 
and BNFT (containing functionalized BasO4 nano-particles) (M, N).
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Figure  Representative compressive stress-strain curves for various bone cements. 
One representative of three trials is shown for each bone cement.  Bone cements 
tested included: Plain, ZM (containing micron particulate ZrO2), ZN (containing unfunc-
tionalized ZrO2 nano-particles), ZNFT (containing functionalized ZrO2 nano-particles), 
BM (containing micron particulate BasO4), BN (containing unfunctionalized BasO4 
nano-particles), and BNFT (containing functionalized BasO4 nano-particles). A) All 
bone cements, B) Bone cements containing ZrO2 particles, and C) Bone cements 
containing BasO4 particles.International Journal of Nanomedicine 2010:5 
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Discussion
Most importantly, cytocompatibility results indicated that 
the addition of ceramic particles had a positive impact on 
osteoblast cell density on bone cements. These findings 
were in agreement with a study carried out by Ricker and 
colleagues which demonstrated increased osteoblast density 
on PMMA samples containing ceramic particles, with 
nanoscaling of certain ceramic particles leading to an even 
greater increase in osteoblast density (as also demonstrated 
here).7 Future experiments need to focus on the mechanisms 
of why this occurred (most likely due to optimal initial select 
protein adsorption events important for mediating osteoblast 
adhesion as noted by others on nanoparticulate polymer 
composites).7 In addition, studies to improve the distribution 
of these nanoceramics in bone cements are needed as other 
studies have demonstrated improved cytocompatibility prop-
erties with fully dispersed nanoparticles in polymers.7
In addition, this study provided key information 
concerning mechanical properties of the bone cements when 
compared to natural bone. Due to the presence of collagen in 
bone, plastic deformation regions have been observed which 
are not currently emulated in traditional bone cements.7 In the 
present study, plastic deformation was observed for the bone 
cements containing nanoparticulates. Further, Mente and 
colleagues reported that the Young’s modulus for different 
types of bone are: dry cortical bone: 1.82E + 10 N/m2, 
wet cortical bone: 1.24E + 10 N/m2, and dry trabecular 
bone: 7.80E + 09 N/m2. In this study, the maximum stress 
and Young’s modulus were found for plain bone cements. 
Additionally, the Young’s moduli of bone cements containing 
unfunctionalized ZrO2 micron and nanoparticles were 
higher on average than the Young’s moduli of bone cements 
containing functionalized ZrO2 nanoparticles. On average, 
bone cements containing functionalized BaSO4 nanoparticles 
had a lower Young’s modulus than bone cements containing 
micron BaSO4 particles, but had a higher Young’s modulus 
relative to bone cements containing unfunctionalized BaSO4 
nanoparticles.
Clearly, the stress–strain trends of the bone cements 
formulated in this study under tensile loading indicated an 
inherent tradeoff in the mechanical properties. The addition 
of any ceramic particle was detrimental in that it decreased 
the maximum tolerable tensile stress as well as the Young’s 
modulus of bone cements. However, as mentioned, the addi-
tion of the ceramic nanoparticles functionalized with TMS 
did, however, have positive implications on the mechanical 
properties of bone cements as they drastically changed 
failure modes. The plastic failure mode indicated a potential 
for aversion of the brittle, and often dramatic, failure that is 
frequently found with today’s bone cements. Future studies 
will have to optimize the ceramic weight percent addition to 
PMMA to match the mechanical properties of bone.
Similar promise was observed for the compressive 
properties of the novel bone cements formulated in this study. 
Using the Young’s moduli found by Mente and colleagues, 
the maximum compressive stresses corresponding to 56% 
strain for different types of bone were: dry cortical bone: 
1.02E + 10 N/m2, wet cortical bone: 6.94E + 09 N/m2, and 
Table  Radio-opacity, as indicated by mean gray value, of various 
bone cements. higher mean gray value is indicative of a greater 
degree of radio-opacity. Bone cements analyzed included: Plain, 
ZM (containing micron particulate ZrO2), ZN (containing unfunc-
tionalized ZrO2 nano-particles), ZNFT (containing functionalized 
ZrO2 nano-particles), BM (containing micron particulate BasO4), 
BN (containing unfunctionalized BasO4 nano-particles), and BNFT 
(containing functionalized BasO4 nano-particles)
Substrate Mean gray value (Normalized)
Plain 43.68
ZM 76.59
ZN 76.30
ZNFT 72.66
BM 54.63
BN 49.81
BNFT 63.44
Table  compressive stress required to obtain 56% strain (1 mm 
of compression) in various bone cements: Plain, ZM (containing 
micron particulate ZrO2), ZN (containing unfunctionalized ZrO2 
nano-particles), ZNFT (containing functionalized ZrO2 nano-
particles), BM (containing micron particulate BasO4), BN (containing 
unfunctionalized BasO4 nano-particles), and BNFT (containing 
functionalized BasO4 nano-particles). Maximum compressive 
stress at 56% strain for bone calculated from  Young’s moduli values 
obtained from study by Mente et al
Substrate  Maximum compressive  
stress (N/m)
Plain -3.63e + 07
BN -2.36e + 07
ZNFT -2.36e + 07
BNFT -1.90e + 07
ZN -1.04e + 07
BM -9.71e + 06
ZM -7.50e + 06
cortical bone – dry -1.02e + 10
cortical bone – wet -6.94e + 09
Trabecular bone – dry -4.37e + 09International Journal of Nanomedicine 2010:5 0
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dry trabecular bone: 4.37E + 09 N/m2. In this study, unmodi-
fied bone cements had the greatest compressive stress at 56% 
strain and were most similar to bone. Among bone cements 
containing ZrO2 particles, those containing functionalized 
nanoparticles were the least easily compressed to obtain 56% 
strain, followed by bone cements containing unfunctionalized 
nanoparticles, and finally by bone cements containing micron 
particles. Among bone cements containing BaSO4 particles, 
those containing unfunctionalized nanoparticles were most 
easily compressed, followed by bone cements containing 
functionalized nanoparticles, and finally by bone cements 
containing micron particles.
In summary, results of the mechanical portion of this 
study demonstrated a strong ability to tweak mechanical 
properties of bone cements with nanometer chemically 
functionally functionalized particles, even achieving plastic 
deformation regions before failure similar to that of natu-
ral bone.
Clearly, one of the largest disadvantages of today’s 
bone cements is that they are largely exothermic, damaging 
juxtaposed bone and increasing healing time. The exothermic 
reaction results from this study did, however, deviate from 
the findings of Ricker and colleagues who demonstrated a 
markedly decreased temperature change during polymer-
ization of bone cements containing ceramic nanoparticles 
compared to bone cements containing no ceramic particles 
or those containing micron ceramic particles.7 One plausible 
explanation for the variation observed here compared to 
such previous studies could be that different ceramic weight 
percentages were used in this study; such deviation needs to 
be the focus of future studies.
Lastly, bone cements needs to be radio-opaque in order 
for proper clinical analysis of bone growth next to bone 
cements. The radio-opacity experimental results from 
this study were in agreement with the work of Ricker 
and colleagues who demonstrated greater radio-opacity 
with nanometer particles compared to micron particle-
doped bone cements.7 Moreover, here it was observed 
that the radio-opacity of bone cements with chemically 
functionalized ZrO2 nanoparticles was found to be less 
than the radio-opacity of bone cements with unfunction-
alized ZrO2 micron- and nanoparticles. In contrast, the 
radio-opacity of bone cements with functionalized BaSO4 
nanoparticles was found to be even greater than the radio-
opacity of bone cements with unfunctionalized BaSO4 
micron- and nanoparticles. Finally, it was also found that 
bone cements containing ZrO2 were more radio-opaque 
than those containing BaSO4 for all particle types: micron, 
nano, and nanofunctionalized. While all ceramic particles 
significantly increased the radio-opacity of bone cements, 
the results indicated that ZrO2 was relatively better than 
BaSO4 at doing so.
Conclusions
Recent research in biomaterials has focused on improving 
biocompatibility properties. Understanding the interaction 
of biomaterials with tissue in situ is of paramount impor-
tance towards improving their function and integration into 
the body.11 Research has shown that PMMA often elicits an 
auto-immune response within the body, which may lead to 
fibrous encapsulation and other physiological responses that 
destabilize and decrease biocompatibility at the bone-implant 
interface. In an effort to improve properties of bone cement, 
Atsushi and colleagues functionalized PMMA with TMS 
and found that compared to unmodified bone cement, this 
modified bone cement increased osteoconductivity.12 Recent 
studies have also determined that PMMA/hydroxyapatite/
nanoclay bone cements promoted osteoconductivity and 
possessed improved mechanical properties (such as the 
ability to withstand tensile and shear stresses) compared to 
unmodified PMMA.13
A similar effort was used here to improve properties 
of PMMA, however, it focused more on nanotechnology 
approaches. ZrO2 and BaSO4 micronscale, nanoscale, and 
nanoscale TMS functionalized particles were introduced into 
bone cements. Bone cements were subsequently examined 
for their cytocompatibility and mechanical properties. It was 
shown that these ceramic particles, which are currently used 
to aid in the diagnosis of bone cement efficacy through X-ray 
imaging, did indeed increase cytocompatibility properties, 
alter mechanical failure mode, and increase the radio-opacity 
of bone cements. There were no significant differences found 
in the exothermic polymerization temperatures for any of 
the bone cements formulated here over time. Bone cements 
containing nanometer ZrO2 or BaSO4 particles functionalized 
with TMS showed the most promise for improving cytocom-
patibility properties and promoting plastic rather than brittle 
tensile mechanical failure; as such, they should be further 
studied for improving properties of traditional PMMA for 
orthopedic applications.
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